Colorectal Cancer (CRC) Recruiting Phase 1 Trials for Capecitabine (DB01101)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT07805551	A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) HDM2017 (DB31838) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT07365592	Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526) Sitagliptin (DB01261)
NCT06324357	Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread	Treatment	Capecitabine (DB01101) Deruxtecan (DB22781) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526) Trastuzumab (DB00072) Trastuzumab deruxtecan (DB14962) Trastuzumab emtansine (DB05773) Zanidatamab (DB15471) Zongertinib (DB18762)
NCT06848465	LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis	Treatment	Capecitabine (DB01101) Oxaliplatin (DB00526) Tislelizumab (DB14922)
NCT06621563	Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors	Treatment	Capecitabine (DB01101) Cisplatin (DB00515) Fluorouracil (DB00544) HS-20117 (DB23695) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526) Pemetrexed (DB00642) Platinum (DB12257) Risvutatug rezetecan (DB23560)
NCT04920032	Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Tipiracil (DB09343) Trifluridine (DB00432)
NCT07283367	A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) HS-20110 (DB23824) Leucovorin (DB00650) Oxaliplatin (DB00526)